Chapter 75. Secondary Prevention Strategies Post Myocardial Infarction

  1. Salim Yusuf DPhil, FRCPC, FRSC Research Chair Professor of Medicine Director Vice President Research2,3,4,
  2. John A Cairns MD, FRCPC Professor of Medicine Former Dean5,
  3. A John Camm MD British Heart Foundation Professor Head of Cardiac6,
  4. Ernest L Fallen MD, FRCPC Professor Emeritus7 and
  5. Bernard J Gersh MB, ChB, DPhil Consultant Professor of Medicine8
  1. Jacques Genest Jr MD, FRCPC Professor Chair Director

Published Online: 21 MAY 2010

DOI: 10.1002/9781444309768.ch75

Evidence-Based Cardiology, Third Edition

Evidence-Based Cardiology, Third Edition

How to Cite

Genest, J. (2009) Secondary Prevention Strategies Post Myocardial Infarction, in Evidence-Based Cardiology, Third Edition (eds S. Yusuf, J. A. Cairns, A. J. Camm, E. L. Fallen and B. J. Gersh), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444309768.ch75

Editor Information

  1. 2

    McMaster University, Canada

  2. 3

    Population Health Research Institute, McMaster University, Hamilton Health Sciences, Canada

  3. 4

    Hamilton Health Sciences, Hamilton, Ontario, Canada

  4. 5

    Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

  5. 6

    St George's University of London, London, UK

  6. 7

    McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada

  7. 8

    Mayo Clinic College of Medicine, Rochester, MN, USA

Author Information

  1. Faculty of Medicine, McGill University, Novartis in Medicine at McGill University, Division of Cardiology University Health Center/Royal Victoria Hospital, Montreal, Quebec, Canada

Publication History

  1. Published Online: 21 MAY 2010
  2. Published Print: 13 NOV 2009

ISBN Information

Print ISBN: 9781405159258

Online ISBN: 9781444309768



  • secondary prevention strategies post myocardial infarction;
  • statin treatment and pharmacological HDL-C raise;
  • elevated HDL-C serum level - cardiovascular health biomarker;
  • cardiovascular diseases preventive strategies, secondary - smoking cessation;
  • statins' effect on HDL-C - plasma triglycerides decrease;
  • apolipoprotein AI (apo AI) transcriptional regulation;
  • fibrates usage and cardiovascular diseases prevention;
  • HDL-C increase - novel and molecular approaches


This chapter contains sections titled:

  • Conclusion

  • References